表紙
市場調査レポート

中国のアルツハイマー病治療薬市場

Alzheimer Disease Drugs Markets in China

発行 Asia Market Information & Development 商品コード 86316
出版日 ページ情報 英文 239 Pages
即納可能
価格
本日の銀行送金レート: 1USD=104.18円で換算しております。
Back to Top
中国のアルツハイマー病治療薬市場 Alzheimer Disease Drugs Markets in China
出版日: 2016年05月01日 ページ情報: 英文 239 Pages
概要

当レポートでは、中国におけるアルツハイマー病の治療薬市場の投資環境、産業の発展、需要と供給、産業構造、市場チャネル、主要企業などについて詳細に調査し、実績や長期予測を提供しています。

第1章 イントロダクション

  • 本調査書の範囲と方法論
  • エグゼクティブサマリー

第2章 ビジネス環境

  • 経済展望
    • 主な経済指標
    • 工業生産高
    • 人口および労働力
    • 海外からの投資
    • 海外貿易
  • 金融および税金の規制
    • 銀行制度および規制
    • 外国為替
    • 税金、関税および税関

第3章 アルツハイマー病治療薬産業のアセスメント

  • 産業構造
  • 市場規模
  • 市場成長促進要因
  • 売上高
  • 主要メーカーの設備拠点および売上高
  • 主要メーカーの市場シェア
  • 労働コスト
  • 潜在性のある参入企業
  • 主な流通企業
  • 主な海外からの投資
  • 技術開発

第4章 アルツハイマー病治療薬の生産および需要

  • 概要
  • 地域別需要
  • 売上高および輸入量
    • Ginkgo Bilota Extract
    • Breviscapine
    • Ganglioside
    • Donepezil
    • Galanthamine
    • Nicergoline
    • Rivastigmine
    • Memantine
    • Huperzine A
    • Oxiracetam
    • Flunarizine
    • Piracetam
    • その他
  • 価格動向

第5章 アルツハイマー病治療薬の市場展望

  • 市場の展望
  • 政府の規制
  • 医療保険産業の展望
  • 消費者支出の動向
  • 人口動態
  • 医療産業の動向
  • 病院および病床
  • 医師および往診

第6章 市場戦略

  • 中国市場参入の概要
    • 流通システム
    • アルツハイマー病治療薬の流通チャネル
    • 運輸および輸送インフラ
    • 通信
  • 中国市場への参入
    • 対中国輸出
    • 間接輸出
    • 直接輸出
    • ライセンスおよび提携製造
    • 中国内組み立て
    • 提携製造
    • 貿易許可
    • 投資
    • 資本提携
    • 共同提携
    • 完全外資企業

第7章 アルツハイマー病治療薬メーカーのディレクトリー

  • メーカーのプロファイル
  • 流通業者および貿易会社
  • 協会および研究機関
  • 主なエンドユーザー

図表リスト

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: 801

China's demand for Alzheimer Disease Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2005, 2010 and 2015) and long-term forecasts through 2020 and 2025 are presented. Major producers in China are profiled.

The primary and secondary research is done in China in order to access up-to-date government regulations, market information and industry data. Data were collected from the Chinese government publications, Chinese language newspapers and magazines, industry associations, local governments' industry bureaus, industry publications, and our in-house databases. Interviews are conducted with Chinese industry experts, university professors, and producers in China. Economic models and quantitative methods are applied in this report to project market demand and industry trends. Metric system is used and values are presented in either Yuan (RMB, current price) and/or US dollars.

Our market research reports provide hard-to-find market data and analyses. Today, China has the largest market in the world. Tremendous fast-growing markets for imports and business opportunities for companies around the world. If you want to expand your business or sell your products in China, our research reports provide the insights and projections into Chinese markets necessary for you to do so.

TABLE OF CONTENTS

I. INTRODUCTION

  • Report Scope and Methodology
  • Executive Summary

II. BUSINESS ENVIRONMENT

  • Economic Outlook
  • Key Economic Indicators
  • Industrial Output
  • Population and Labor
  • Foreign Investment
  • Foreign Trade
  • Financial and Tax Regulations
  • Banking System and Regulations
  • Foreign Exchange
  • Taxes, Tariff and Custom Duties

III. ALZHEIMER'S DISEASE DRUGS INDUSTRY ASSESSMENTS

  • Alzheimer's Disease Drugs Industry Structure
  • Market Size
  • Market Growth Drivers
  • Alzheimer's Disease Drugs Sales Volume
  • Major Producer Facility Locations and Sales Volume
  • Market Share of Key Producers
  • Labor Cost
  • Potential Entrants
  • Major Distributors
  • Major Foreign Investments
  • Technology Development

IV. ALZHEIMER'S DISEASE DRUGS PRODUCTION AND DEMAND

  • Overview
  • Demand of Alzheimer's Disease Drugs by Region
  • Alzheimer's Disease Drugs Sales Volume
  • Ginkgo Bilota Extract
  • Breviscapine
  • Ganglioside
  • Donepezil
  • Galanthamine
  • Nicergoline
  • Rivastigmine
  • Memantine
  • Huperzine A
  • Oxiracetam
  • Flunarizine
  • Piracetam
  • Other Alzheimer's Disease Drugs
  • Alzheimer's Disease Drugs Imports
  • Ginkgo Bilota Extract Imports
  • Breviscapine Imports
  • Ganglioside Imports
  • Donepezil Imports
  • Galanthamine Imports
  • Nicergoline Imports
  • Rivastigmine Imports
  • Memantine Imports
  • Huperzine A Imports
  • Oxiracetam Imports
  • Flunarizine Imports
  • Piracetam Imports
  • Other Alzheimer's Disease Drugs Imports
  • Pricing Trend

V. ALZHEIMER'S DISEASE DRUGS MARKET OUTLOOK

  • Alzheimer's Disease Drugs Markets Outlook Overview
  • Government Regulations
  • Health Care Insurance Industry Overview
  • Consumer Spending Trends By Region
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds
  • Physicians and Physician Visits

V. MARKETING STRATEGIES

  • China Market Entry Overview
  • China's Distribution System
  • Rubber Processing Chemicals Distribution Channels
  • Transportation and Freight Infrastructure
  • Communications
  • China's Market Entry
  • Licensing
  • Franchising
  • E-commerce
  • Trading Companies and Local Agents
  • Representative Offices and Chinese Subsidiaries
  • Wholly Foreign Owned Enterprises

VII. ALZHEIMER'S DISEASE DRUGS PRODUCER DIRECTORY

  • Major Alzheimer's Disease Drugs Producer Profiles
  • Distributors and Trading Companies
  • Associations and Research Institutes
  • Major End-Users

LIST OF TABLES

I. INTRODUCTION

  • Economic Outlook Summary

II. BUSINESS ENVIRONMENT

  • Key Economic Indicators
  • Industrial Output
  • Population and Labor Force Trends
  • Foreign Investment and Loans
  • Foreign Trade

III. ALZHEIMER'S DISEASE DRUGS INDUSTRY ASSESSMENTS

  • Alzheimer's Disease Drugs Sales Volume
  • Major Producer Facility Locations
  • Major Alzheimer's Disease Drugs Producer Sales Volume
  • Market Share of Key Producers
  • Major Foreign Investments

IV. ALZHEIMER'S DISEASE DRUGS PRODUCTION AND DEMAND

  • Total Alzheimer's Disease Drugs Sales Volume
  • Alzheimer's Disease Drugs Major Producer and Their Market Share
  • Ginkgo Bilota Extract Major Producer and Their Market Share
  • Breviscapine Major Producer and Their Market Share
  • Ganglioside Major Producer and Their Market Share
  • Donepezil Major Producer and Their Market Share
  • Galanthamine Major Producer and Their Market Share
  • Dihydroergotamine Major Producer and Their Market Share
  • Rivastigmine Major Producer and Their Market Share
  • Memantine Major Producer and Their Market Share
  • Huperzine A Major Producer and Their Market Share
  • Oxiracetam Major Producer and Their Market Share
  • Flunarizine Major Producer and Their Market Share
  • Piracetam Major Producer and Their Market Share
  • Alzheimer's Disease Drugs Import

V. ALZHEIMER'S DISEASE DRUGS MARKET OUTLOOK

  • Consumer Spending Trend
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds
  • Physicians and Physician Visits

LIST OF CHARTS

I. INTRODUCTION

  • Alzheimer's Disease Drugs Sales Volume

II. BUSINESS ENVIRONMENT

  • China's GDP and Industrial Output
  • Industrial Output by Ownership
  • China's Imports and Exports

III. ALZHEIMER'S DISEASE DRUGS INDUSTRY ASSESSMENTS

  • Alzheimer's Disease Drugs Sales Volume

II. ALZHEIMER'S DISEASE DRUGS PRODUCTION AND DEMAND

  • Alzheimer's Disease Drugs Sales Volume
  • Worldwide Alzheimer's Disease Drugs Demand by Region
  • Ginkgo Bilota Extract Sales Volume and Market Share
  • Breviscapine Sales Volume and Market Share
  • Ganglioside Sales Volume and Market Share
  • Donepezil Sales Volume and Market Share
  • Galanthamine Sales Volume and Market Share
  • Dihydroergotamine Sales Volume and Market Share
  • Rivastigmine Sales Volume and Market Share
  • Memantine Sales Volume and Market Share
  • Huperzine A Sales Volume and Market Share
  • Oxiracetam Sales Volume and Market Share
  • Flunarizine Sales Volume and Market Share
  • Piracetam Sales Volume and Market Share
  • Other Alzheimer's Disease Drugs Sales volume and market share
  • Alzheimer's Disease Drugs Import Volume
  • Ginkgo Bilota Extract Import Volume and Market Share
  • Breviscapine Import Volume and Market Share
  • Ganglioside Import Volume and Market Share
  • Donepezil Import Volume and Market Share
  • Galanthamine Import Volume and Market Share
  • Dihydroergotamine Import Volume and Market Share
  • Rivastigmine Import Volume and Market Share
  • Memantine Import Volume and Market Share
  • Huperzine A Import Volume and Market Share
  • Oxiracetam Import Volume and Market Share
  • Flunarizine Import Volume and Market Share
  • Piracetam Import Volume and Market Share
  • Other Alzheimer's Disease Drugs Import Volume and Market Share

VI. MARKETING STRATEGIES

  • China's Distribution Channel
Back to Top